Daewoong Pharmaceutical Co. Ltd.
Clinical trials sponsored by Daewoong Pharmaceutical Co. Ltd., explained in plain language.
-
New study tests psoriasis pill for clearer skin
Disease control Not yet recruitingThis study tests a pill called apremilast in 425 adults with moderate-to-severe psoriasis that has lasted at least 6 months. The goal is to see if it improves skin symptoms like redness and scaling over 32 weeks. Participants take the medication and are monitored for safety and e…
Sponsor: Daewoong Pharmaceutical Co. LTD. • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New pill aims to shield stomachs from painkiller damage
Prevention Not yet recruitingThis study tests whether a new medicine called Fexuprazan can prevent stomach ulcers in people who need to take NSAID pain relievers (like ibuprofen) for at least 24 weeks. About 360 adults with joint or muscle pain will receive either Fexuprazan or an older ulcer-prevention drug…
Phase: PHASE4 • Sponsor: Daewoong Pharmaceutical Co. LTD. • Aim: Prevention
Last updated May 11, 2026 20:50 UTC
-
New obesity drug candidate put to the test in healthy volunteers
Knowledge-focused Not yet recruitingThis early-stage study tests whether a new drug called DWRX5003 is safe in healthy adults aged 19 to 65. It also measures how the drug moves through the body compared to two other versions. The goal is to gather safety and processing data, not to treat any disease.
Phase: PHASE1 • Sponsor: Daewoong Pharmaceutical Co. LTD. • Aim: Knowledge-focused
Last updated May 17, 2026 03:18 UTC